Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
VentriPoint Diagnostics Ltd
V.VPT
Alternate Symbol(s):
VPTDF
Healthcare
Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and...
cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:VPT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 15, 2024 8:12am
New Press Release - Ventripoint Announces Extension of Private Placement Offerings and Upsize of Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption
(TheNewswire)Toronto, Ontario – TheNewswire - October 15, 2024– Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Corporation”), (TSXV:VPT) announces that it has received approval of TSX Venture Exchange (“TSXV” or the “Exchange”) to extend its previously announced non-brokered private...
read article.
(12)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Oct 15, 2024 6:56am
BSEcho2024 pleasure to share the stage post Dario Freitas🚀
Interesting & remember on Dario Freitas (PHD study using Ventripoint - Dario Freitas) And I think they know more about the Ventripoint tech than the whiners on this board.I also think that
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(12)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Oct 14, 2024 4:31pm
RE:RE:Ventripoint submits VMS+4.0 for EU MDR approval 2024-10-11
Good comment @hassy There are more near term catalysts on the horizon than 4.0- including more sales in EU, high profile sale in US etc. Market time is absolutely horrible for juniors in
...more
(12)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Oct 14, 2024 4:12pm
RE:GranhamF the Vultur Back to 0.1099 (15 cents) on the US side
GranhamF the Fud lol and the facts Overcoming Challenges in Echocardiography Interpretation with Next-Generation Solutions GEN3ECHO https://www.linkedin.com/pulse/overcoming-challenges
...more
(12)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Oct 14, 2024 3:57pm
GranhamF the Vultur Back to 0.1099 (15 cents) on the US side
Remember Hugh MacNaught “As more hospitals look to Ventripoint to provide advanced whole-heart analysis, this MDR submission is an important next step in the development and commercialization of
...more
(1269)
•••
GrahamB
X
View Profile
View Bullboard History
Post by
GrahamB
on Oct 14, 2024 1:12pm
Beautiful fall or a falling knife?
Checking in with Ventripointers, to see if the financing closed and financials should be due soon. I noticed the stock is down double digits to .09c US, if my read is correct, on decent volume? Is
...more
(12)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Oct 14, 2024 11:16am
RE:Ventripoint submits VMS+4.0 for EU MDR approval 2024-10-11
Now maybe Planning to be at the meeting in Toronto? MedTechConference2024 https://themedtechconference.com/ Any know Ventripoint ?(Planning to be at the meeting in Toronto?) The MedTech
...more
(12)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Oct 14, 2024 10:29am
Ventripoint submits VMS+4.0 for EU MDR approval 2024-10-11
Very Good Ventripoint submits VMS+4.0 for EU MDR approval 2024-10-11 10:20 ET - News Release Mr. Hugh MacNaught reports VENTRIPOINT'S NEXT GENERATION, AI-POWERED HEART-SCANNING TECHNOLOGY
...more
(12)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Oct 14, 2024 9:26am
RE:RE:Stop being so negative.
Enough The fud remenber 4.0 will be approved around the world.and Overcoming Challenges in Echocardiography Interpretation with Next-Generation Solutions GEN3ECHO https://www.linkedin
...more
(12)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Oct 13, 2024 7:17pm
BSEcho 2024📅 the role of AI in Echo 👀post Hannah Crane 👏
Dario Freitas commented on this Hannah CraneHannah Crane • 3rd+ • 3rd+Clinical Applications Specialist & Cardiac
...more
(12)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Oct 13, 2024 7:09pm
Ventripoint's VMS+ and why adding this solution BSEcho2024 !
Interesting( Ventripoint's VMS+ and why adding this solution will benefit their patients in daily practice. hashtag#BSEcho2024 ) Hugh MacNaught likes this
...more
(12)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Oct 13, 2024 8:52am
RE:Next Génération Solution GEN3ECHO
interesting Read on GEN3ECHO Overcoming Challenges in Echocardiography Interpretation with Next-Generation Solutions ASCEND Cardiovascular
...more
(12)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Oct 12, 2024 10:43pm
Next Génération Solution GEN3ECHO
ASCEND Cardiovascular 1,044 followers 2d Follow ASCEND is dedicated to resolving common obstacles in echocardiography. Discover the challenges and explore our
...more
(16)
•••
Enough
X
View Profile
View Bullboard History
Comment by
Enough
on Oct 12, 2024 12:40pm
RE:RE:Stop being so negative.
Doesn't matter if it's approved everywhere in the world if it doesn't sell any units. Time for some tough love here. How can you sell units with a tiny salesforce? How many sales teams
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden